Compare Abbott India with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs CADILA HEALTHCARE - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA CADILA HEALTHCARE ABBOTT INDIA/
CADILA HEALTHCARE
 
P/E (TTM) x 49.0 29.7 165.2% View Chart
P/BV x 15.8 5.2 304.4% View Chart
Dividend Yield % 0.4 0.7 65.4%  

Financials

 ABBOTT INDIA   CADILA HEALTHCARE
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
CADILA HEALTHCARE
Mar-20
ABBOTT INDIA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs8,834352 2,507.6%   
Low Rs5,458207 2,642.9%   
Sales per share (Unadj.) Rs1,731.1139.2 1,243.4%  
Earnings per share (Unadj.) Rs211.911.8 1,801.3%  
Cash flow per share (Unadj.) Rs219.918.6 1,184.2%  
Dividends per share (Unadj.) Rs65.003.50 1,857.1%  
Dividend yield (eoy) %0.91.3 72.6%  
Book value per share (Unadj.) Rs945.2101.4 932.6%  
Shares outstanding (eoy) m21.251,023.74 2.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.12.0 205.7%   
Avg P/E ratio x33.723.7 142.0%  
P/CF ratio (eoy) x32.515.0 216.0%  
Price / Book Value ratio x7.62.8 274.2%  
Dividend payout %30.729.8 103.1%   
Avg Mkt Cap Rs m151,848286,033 53.1%   
No. of employees `0003.513.4 26.0%   
Total wages/salary Rs m4,35624,145 18.0%   
Avg. sales/employee Rs Th10,555.510,632.7 99.3%   
Avg. wages/employee Rs Th1,249.91,801.2 69.4%   
Avg. net profit/employee Rs Th1,292.2898.5 143.8%   
INCOME DATA
Net Sales Rs m36,786142,531 25.8%  
Other income Rs m1,1331,139 99.5%   
Total revenues Rs m37,919143,670 26.4%   
Gross profit Rs m6,04724,198 25.0%  
Depreciation Rs m1696,965 2.4%   
Interest Rs m233,418 0.7%   
Profit before tax Rs m6,98914,954 46.7%   
Minority Interest Rs m0288 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4853,198 77.7%   
Profit after tax Rs m4,50312,044 37.4%  
Gross profit margin %16.417.0 96.8%  
Effective tax rate %35.621.4 166.3%   
Net profit margin %12.28.5 144.9%  
BALANCE SHEET DATA
Current assets Rs m27,61087,154 31.7%   
Current liabilities Rs m8,56982,694 10.4%   
Net working cap to sales %51.83.1 1,654.2%  
Current ratio x3.21.1 305.7%  
Inventory Days Days6071 84.3%  
Debtors Days Days2794 29.2%  
Net fixed assets Rs m1,057133,236 0.8%   
Share capital Rs m2131,024 20.8%   
"Free" reserves Rs m19,873102,733 19.3%   
Net worth Rs m20,086103,757 19.4%   
Long term debt Rs m032,146 0.0%   
Total assets Rs m29,409236,866 12.4%  
Interest coverage x311.65.4 5,797.1%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.30.6 207.9%   
Return on assets %15.46.5 235.7%  
Return on equity %22.411.6 193.1%  
Return on capital %34.913.7 254.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36952,752 0.7%   
Fx outflow Rs m4,91814,504 33.9%   
Net fx Rs m-4,54938,248 -11.9%   
CASH FLOW
From Operations Rs m4,99125,054 19.9%  
From Investments Rs m-2,570-10,123 25.4%  
From Financial Activity Rs m-1,428-10,942 13.1%  
Net Cashflow Rs m9933,989 24.9%  

Share Holding

Indian Promoters % 0.0 74.8 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 8.3 95.2%  
FIIs % 0.1 5.9 1.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 11.0 155.5%  
Shareholders   18,270 44,069 41.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DR. DATSONS LABS  DISHMAN PHARMA  J.B.CHEMICALS  JUBILANT PHARMOVA   DIVIS LABORATORIES  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Apr 16, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS